196 related articles for article (PubMed ID: 8975729)
21. Wilms tumor and the WT1 gene.
Lee SB; Haber DA
Exp Cell Res; 2001 Mar; 264(1):74-99. PubMed ID: 11237525
[TBL] [Abstract][Full Text] [Related]
22. [The aniridia-Wilms' tumor syndrome: a familial case].
Vadot E; Noel B; Vercherat M
Bull Soc Ophtalmol Fr; 1987 Nov; 87(11):1315-7. PubMed ID: 2837344
[No Abstract] [Full Text] [Related]
23. [The Wilms' tumor suppressor gene WT1].
Akiyama T
Tanpakushitsu Kakusan Koso; 1997 Jul; 42(10 Suppl):1612-7. PubMed ID: 9279088
[No Abstract] [Full Text] [Related]
24. Biology of Wilms' tumour.
Pritchard-Jones K; Hawkins MM
Lancet; 1997 Mar; 349(9053):663-4. PubMed ID: 9078193
[No Abstract] [Full Text] [Related]
25. Wilms' tumour: reconciling genetics and biology.
Van Heyningen V; Hastie ND
Trends Genet; 1992 Jan; 8(1):16-21. PubMed ID: 1369730
[TBL] [Abstract][Full Text] [Related]
26. The familial Wilms' tumour susceptibility gene, FWT1, may not be a tumour suppressor gene.
Rahman N; Arbour L; Tonin P; Baruchel S; Pritchard-Jones K; Narod SA; Stratton MR
Oncogene; 1997 Jun; 14(25):3099-102. PubMed ID: 9223674
[TBL] [Abstract][Full Text] [Related]
27. Frequency and heritability of WT1 mutations in nonsyndromic Wilms' tumor patients: a UK Children's Cancer Study Group Study.
Little SE; Hanks SP; King-Underwood L; Jones C; Rapley EA; Rahman N; Pritchard-Jones K
J Clin Oncol; 2004 Oct; 22(20):4140-6. PubMed ID: 15483024
[TBL] [Abstract][Full Text] [Related]
28. Evidence for genetic heterogeneity in familial Wilms' tumor.
Huff V; Amos CI; Douglass EC; Fisher R; Geiser CF; Krill CE; Li FP; Strong LC; McDonald JM
Cancer Res; 1997 May; 57(10):1859-62. PubMed ID: 9157975
[TBL] [Abstract][Full Text] [Related]
29. [Molecular genetics of Wilms' tumor].
Papezová M; Mares J; Goetz P
Cas Lek Cesk; 2001 Jun; 140(11):323-7. PubMed ID: 11431850
[TBL] [Abstract][Full Text] [Related]
30. Wilms' tumor-specific methylation pattern in 11p13 detected by PFGE.
Royer-Pokora B; Schneider S
Genes Chromosomes Cancer; 1992 Sep; 5(2):132-40. PubMed ID: 1381949
[TBL] [Abstract][Full Text] [Related]
31. Paternally inherited WT1 mutation plus uniparental disomy of 11p may be an essential mechanism for development of WT1-mutated familial Wilms tumor.
Sato Y; Haruta M; Kaneko Y; Nakasato Y; Kurosawa H; Yoshihara S
Pediatr Blood Cancer; 2019 Jan; 66(1):e27442. PubMed ID: 30221469
[No Abstract] [Full Text] [Related]
32. Imbalanced expression of functionally different WT1 isoforms may contribute to sporadic unilateral Wilms' tumor.
Liu JJ; Wang ZY; Deuel TF; Xu YH
Biochem Biophys Res Commun; 1999 Jan; 254(1):197-9. PubMed ID: 9920757
[TBL] [Abstract][Full Text] [Related]
33. Paternally inherited submicroscopic duplication at 11p15.5 implicates insulin-like growth factor II in overgrowth and Wilms' tumorigenesis.
Algar EM; St Heaps L; Darmanian A; Dagar V; Prawitt D; Peters GB; Collins F
Cancer Res; 2007 Mar; 67(5):2360-5. PubMed ID: 17325026
[TBL] [Abstract][Full Text] [Related]
34. Wilms' tumour: connecting tumorigenesis and organ development in the kidney.
Rivera MN; Haber DA
Nat Rev Cancer; 2005 Sep; 5(9):699-712. PubMed ID: 16110318
[TBL] [Abstract][Full Text] [Related]
35. The same mutation affecting the splicing of WT1 gene is present on Frasier syndrome patients with or without Wilms' tumor.
Barbosa AS; Hadjiathanasiou CG; Theodoridis C; Papathanasiou A; Tar A; Merksz M; Györvári B; Sultan C; Dumas R; Jaubert F; Niaudet P; Moreira-Filho CA; Cotinot C; Fellous M
Hum Mutat; 1999; 13(2):146-53. PubMed ID: 10094551
[TBL] [Abstract][Full Text] [Related]
36. Evidence for susceptibility genes to familial Wilms tumour in addition to WT1, FWT1 and FWT2.
Rapley EA; Barfoot R; Bonaïti-Pellié C; Chompret A; Foulkes W; Perusinghe N; Reeve A; Royer-Pokora B; Schumacher V; Shelling A; Skeen J; de Tourreil S; Weirich A; Pritchard-Jones K; Stratton MR; Rahman N
Br J Cancer; 2000 Jul; 83(2):177-83. PubMed ID: 10901367
[TBL] [Abstract][Full Text] [Related]
37. Genetic mosaicism in normal tissues of Wilms' tumour patients.
Chao LY; Huff V; Tomlinson G; Riccardi VM; Strong LC; Saunders GF
Nat Genet; 1993 Feb; 3(2):127-31. PubMed ID: 8388768
[TBL] [Abstract][Full Text] [Related]
38. Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric Oncology Study 9/Society for Pediatric Oncology.
Royer-Pokora B; Weirich A; Schumacher V; Uschkereit C; Beier M; Leuschner I; Graf N; Autschbach F; Schneider D; von Harrach M
Cancer; 2008 Sep; 113(5):1080-9. PubMed ID: 18618575
[TBL] [Abstract][Full Text] [Related]
39. Convergent evolution of 11p allelic loss in multifocal Wilms tumors arising in WT1 mutation carriers.
Valind A; Wessman S; Pal N; Karlsson J; Jonson T; Sandstedt B; Gisselsson D
Pediatr Blood Cancer; 2018 Nov; 65(11):e27301. PubMed ID: 29968962
[TBL] [Abstract][Full Text] [Related]
40. WT1 expression alters tumorigenicity of the G401 kidney-derived cell line.
McMaster ML; Gessler M; Stanbridge EJ; Weissman BE
Cell Growth Differ; 1995 Dec; 6(12):1609-17. PubMed ID: 9019166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
